Source:http://linkedlifedata.com/resource/pubmed/id/11275628
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
2001-3-29
|
pubmed:abstractText |
The etiology of minimal-change nephrotic syndrome (MCNS) is poorly understood. It has been proposed that cell-mediated immunity and T-cell activation are key features of this glomerular disease. Interleukin (IL)-18, a novel interferon-gamma-stimulating factor, may act as an important effector molecule involved in various immune responses. To our knowledge, very little is known about the involvement of IL-18 in NCNS. The aim here was to define further the involvement of IL-18 in MCNS.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0250-8095
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
21
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
20-7
|
pubmed:dateRevised |
2007-2-14
|
pubmed:meshHeading |
pubmed-meshheading:11275628-Adult,
pubmed-meshheading:11275628-Female,
pubmed-meshheading:11275628-Humans,
pubmed-meshheading:11275628-Interleukin-18,
pubmed-meshheading:11275628-Male,
pubmed-meshheading:11275628-Middle Aged,
pubmed-meshheading:11275628-Monocytes,
pubmed-meshheading:11275628-Nephrosis, Lipoid
|
pubmed:articleTitle |
Augmented interleukin-18 production by peripheral blood monocytes in patients with minimal-change nephrotic syndrome.
|
pubmed:affiliation |
Department of Medical Technology, College of Medical Sciences, Saitama Prefectural University, Koshigaya, Japan.
|
pubmed:publicationType |
Journal Article
|